MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1

被引:111
作者
AERTGEERTS, K
DEBONDT, HL
DERANTER, CJ
DECLERCK, PJ
机构
[1] CATHOLIC UNIV LEUVEN, FAC PHARMACEUT SCI, ANALYT CHEM & MED PHYSICOCHEM LAB, B-3000 LOUVAIN, BELGIUM
[2] CATHOLIC UNIV LEUVEN, FAC PHARMACEUT SCI, PHARMACEUT BIOL & PHYTOPHARMACOL LAB, B-3000 LOUVAIN, BELGIUM
来源
NATURE STRUCTURAL BIOLOGY | 1995年 / 2卷 / 10期
关键词
D O I
10.1038/nsb1095-891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor-1 (PAl-1) is unique among the serine proteinase inhibitors (serpins) in that it can adopt at least three different conformations (active, substrate and latent). We report the X-ray structure of a cleaved substrate variant of human PAl-1, which has a new beta-strand s4A formed by insertion of the amino-terminal portion-of the reactive-site loop into beta-sheet A subsequent to cleavage. This is in contrast to the previous suggestion that-the non-inhibitory function of substrate-type serpins is mainly due to an inability of the reactive-site loop to adopt this conformation. Comparison with the structure of latent PAl-1 provides insights into the molecular determinants responsible for the transition of the stressed active conformation to the thermostable latent conformation.
引用
收藏
页码:891 / 897
页数:7
相关论文
共 49 条
[1]   CRYSTALLIZATION AND X-RAY-DIFFRACTION DATA OF THE CLEAVED FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, C ;
DECLERCK, PJ .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1995, 23 (01) :118-121
[2]   A MODEL OF THE REACTIVE FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, C ;
DECLERCK, PJ .
JOURNAL OF STRUCTURAL BIOLOGY, 1994, 113 (03) :239-245
[3]   PURIFICATION AND CHARACTERIZATION OF NATURAL AND RECOMBINANT HUMAN-PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) [J].
ALESSI, MC ;
DECLERCK, PJ ;
DEMOL, M ;
NELLES, L ;
COLLEN, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (03) :531-540
[4]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - REACTIVE CENTER AND AMINO-TERMINAL HETEROGENEITY DETERMINED BY PROTEIN AND CDNA SEQUENCING [J].
ANDREASEN, PA ;
RICCIO, A ;
WELINDER, KG ;
DOUGLAS, R ;
SARTORIO, R ;
NIELSEN, LS ;
OPPENHEIMER, C ;
BLASI, F ;
DANO, K .
FEBS LETTERS, 1986, 209 (02) :213-218
[5]  
[Anonymous], 1992, X PLOR VERSION 3 1 S
[6]  
AUDENAERT AM, 1994, J BIOL CHEM, V269, P19559
[7]   CRYSTAL-STRUCTURE OF CLEAVED HUMAN ALPHA-1-ANTICHYMOTRYPSIN AT 2.7-A RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS [J].
BAUMANN, U ;
HUBER, R ;
BODE, W ;
GROSSE, D ;
LESJAK, M ;
LAURELL, CB .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (03) :595-606
[8]  
BJORK I, 1992, J BIOL CHEM, V267, P1976
[9]   EXTENSION OF MOLECULAR REPLACEMENT - A NEW SEARCH STRATEGY BASED ON PATTERSON CORRELATION REFINEMENT [J].
BRUNGER, AT .
ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 :46-57
[10]   CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS [J].
BRUNGER, AT ;
KURIYAN, J ;
KARPLUS, M .
SCIENCE, 1987, 235 (4787) :458-460